Preferred Name |
nabumetone |
|
Synonyms |
4-(6-methoxynaphthalen-2-yl)butan-2-one 4-(6-Methoxy-2-naphthyl)-2-butanone Relafen |
|
Definitions |
This is any condition in which the main influencing factor is nabumetone, a prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid. Nabumetone is a methyl ketone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with osteoarthritis and rheumatoid arthritis. |
|
ID |
http://purl.obolibrary.org/obo/XCO_0001191 |
|
created_by |
slaulederkind |
|
creation_date |
2023-12-15T11:08:39Z |
|
database_cross_reference |
CID:4409 PMID:32119089 |
|
definition |
This is any condition in which the main influencing factor is nabumetone, a prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid. Nabumetone is a methyl ketone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with osteoarthritis and rheumatoid arthritis. |
|
has_exact_synonym |
4-(6-methoxynaphthalen-2-yl)butan-2-one 4-(6-Methoxy-2-naphthyl)-2-butanone Relafen |
|
has_obo_namespace |
experimental_condition_ontology |
|
id |
XCO:0001191 |
|
label |
nabumetone |
|
notation |
XCO:0001191 |
|
prefLabel |
nabumetone |
|
treeView |
http://purl.obolibrary.org/obo/XCO_0000106 |
|
subClassOf |
http://purl.obolibrary.org/obo/XCO_0000106 |